Celebrex Lawyer
LawyerFinder.com is a FREE consumer service. We are NOT a law firm. We assist consumers in locating Celebrex Lawyers and law firms in specific regions.
We provide comprehensive law firm profiles so that you can review, screen and learn more about our members prior to contacting an attorney. In many cases our Celebrex Lawyer members provide useful articles and example cases to aid you in intelligently choosing the most appropriate legal representation for your unique situation.
To locate a Celebrex Lawyer, simply choose a state from the form to the top right or choose the link from the left hand menu of this page.
Find Celebrex Lawyers. Click on the state below:
Our goal with the Celebrex section of LawyerFinder.com is to try and help legal consumers get in touch with legal professionals practicing Celebrex law, such as: Celebrex lawyers, Celebrex law firm or Celebrex attorneys.
Celebrex News
14 drugs that need more study (Chicago Tribune) | 'Off-Label' Drug Use Is Common (CBS News) It is common for physicians to prescribe drugs for conditions they aren't specifically approved for but in many cases there is not enough evidence to justify the practice, a new report concludes. | Off-label drug testing needed, study says (UPI) STANFORD, Calif., Nov. 25 (UPI) -- Doctors and patients should be concerned about antipsychotic and antidepressant drugs being prescribed for unapproved conditions, U.S. researchers said. | McKesson Settles Class Action Suit for $350 Million (Law.com via Yahoo! Finance) McKesson, the largest drug distributor in the U.S., has agreed to pay $350 million to settle a class action alleging it fraudulently hiked the price of more than 400 medications, including Lipitor, ranked by some indices as the world's top-selling drug as of September. | Study Calls for Greater Scrutiny of 'Off-Label' Drug Use (HealthDay via Yahoo! News) MONDAY, Nov. 24 (HealthDay News) -- It's called "off-label" prescribing, and it's the common practice of doctors prescribing a drug to treat a disease or condition that's different from the one studied by federal regulators that led to the drug's approval in the first place. |

Legal News provided by Yahoo! News! |